TITLE

Treatment of Ocular Cicatricial Pemphigoid with Intravenous Gammaglobulin

AUTHOR(S)
Bohn, Jörg; Benfeldt, Eva; Dabelsteen, Erik; Menné, Torkil
PUB. DATE
July 1998
SOURCE
Acta Dermato-Venereologica;7/21/98, Vol. 78 Issue 4, p316
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Reports the treatment of ocular cicatricial pemphigoid with intravenous gammaglobulin. Effect of the disease on mucous membranes; Details on the clinical characteristics and symptoms of the disease; Significance of systemic steroids on the inhibition of disease progression.
ACCESSION #
4342634

 

Related Articles

  • A systematic review of intravenous gamma globulin for therapy of acute myocarditis. Robinson, Joan L; Hartling, Lisa; Crumley, Ellen; Vandermeer, Ben; Klassen, Terry P // BMC Cardiovascular Disorders;2005, Vol. 5, p12 

    Background: Intravenous gamma globulin (IVGG) is commonly used in the management of acute myocarditis. The objective of this study was to systematically review the literature evaluating this practice. Methods: We conducted a comprehensive search (electronic databases, trials registries,...

  • Treatment With Intravenous Gamma Globulin Infusions. Darmochwal-Kolarz, D. // Fertility Weekly;5/3/2004, p4 

    Examines intravenous infusions of gamma-globulins (IVIG) in a woman with systemic lupus erythematosus. Effectiveness of gamma globulins on infertile patients; Treatment of infertility; Analysis in the administration of an intravenous infusion of immunoglobulin.

  • Efficacy of Intravenous Immunoglobulin in Primary Humoral Immunodeficiency Disease. Cunningham-Rundles, Charlotte; Siegal, Frederick P.; Smithwick, Elizabeth M.; Lion-Boule, Alise; Cunningham-Rundles, Susanna; O'Malley, Joseph; Barandun, Silvio; Good, Robert A. // Annals of Internal Medicine;Oct84, Vol. 101 Issue 4, p435 

    Presents information on a study which examined the use of an intravenous gammaglobulin preparation in patients with primary humoral immunodeficiency disease. Materials and methods; Results; Discussion.

  • Pharmacokinetics of IV Immunoglobulins and Outcome in GBS. Latov, Norman // Hospital Medicine Alert;Mar2010, Vol. 5 Issue 1, p6 

    The article presents an analysis on the study of pharmacokinetics of intravenous (IV) immunoglobulins and on the outcome of Guillain-Barré syndrome (GBS). There were 174 patients with GBS participated in two randomized clinical trials using intravenous gamma globulins (IVIg). The study...

  • Intravenous gammaglobulin suppresses inflammation through a novel TH2 pathway. Anthony, Robert M.; Kobayashi, Toshihiko; Wermeling, Fredrik; Ravetch, Jeffrey V. // Nature;7/1/2011, Vol. 475 Issue 7354, p110 

    High-dose intravenous immunoglobulin is a widely used therapeutic preparation of highly purified immunoglobulin G (IgG) antibodies. It is administered at high doses (1-2 grams per kilogram) for the suppression of autoantibody-triggered inflammation in a variety of clinical settings. This...

  • Gammaglobulina humana. Pulido-Díaz, Nancy; Angulo-Álvarez, Dulce M.; López-Ibarra, Magdalena // Revista Medica del IMSS;2012, Vol. 50 Issue 1, p59 

    Toxic epidermal necrolysis and Stevens Johnson syndrome are severe adverse cutaneous drug reactions that predominantly involve the skin and mucous membranes. We report a case of 43 year old female with 75% body surface area affected, treated with intravenous immunoglobulin who presented...

  • Progress in Gammaglobulin Therapy for Immunodeficiency: From Subcutaneous to Intravenous Infusions and Back Again. Wasserman, Richard // Journal of Clinical Immunology;Dec2012, Vol. 32 Issue 6, p1153 

    The year 1952 marked the first use of subcutaneous immunoglobulin therapy to treat primary immunodeficiency disease. Subsequently, intramuscular and then intravenous administration became the norm in the United States and most of Europe. Intravenous immunoglobulin therapy, however, can be...

  • Pulse methylprednisolone with gammaglobulin as an initial treatment for acute Kawasaki disease. Okada, Keiko; Hara, Junichi; Maki, Ichiro; Miki, Kazunori; Matsuzaki, Kouji; Matsuoka, Taro; Yamamoto, Takehisa; Nishigaki, Toshinori; Kurotobi, Syunji; Sano, Tetsuya; Osaka Kawasaki Disease Study Group // European Journal of Pediatrics;Feb2009, Vol. 168 Issue 2, p181 

    Approximately 15-20% of patients with Kawasaki disease (KD) are not responsive to high-dose intravenous gammaglobulin (IVIG). We have previously reported a predictive method for identifying IVIG-non-responsive patients (high-risk KD patients). We determined the safety and effectiveness of pulse...

  • Intravenous Immunoglobulin for Guillain-Barré Syndrome: How Effective? Ali Tasdemir, Haydar; Dilber, Cergiz; Kanvber, Yilmaz; Uysal, Serap // Journal of Child Neurology;Nov2006, Vol. 21 Issue 11, p972 

    Guillain-Barré syndrome is an acute inflammatory demyelinating neuropathy characterized by progressive symmetric polyradiculoneuritis, predominantly manifested by weakness and areflexia. In this article, we report our findings in 25 children treated with intravenous immunoglobulin and compare...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics